ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,790Medicare Part D Prescriptions Filled, Including Refills

Rank: 135 out of 944

$574K Total Retail Price of All Prescriptions

Rank: 141 out of 944

421 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,468 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 666 578 1 1
OMEPRAZOLE 321 263 2 4
LEVOTHYROXINE SODIUM 313 271 3 2
LISINOPRIL 299 275 4 3
AMLODIPINE BESYLATE 287 251 5 5
ATENOLOL 255 242 6 11
FUROSEMIDE 241 229 7 6
ZOLPIDEM TARTRATE 210 173 8 25
GABAPENTIN 207 180 9 18
METOPROLOL TARTRATE 186 183 10 8
HYDROCODONE-ACETAMINOPHEN 185 147 S3 11 10
HYDROCHLOROTHIAZIDE 184 177 12 9
MELOXICAM 180 158 13 68
ATORVASTATIN CALCIUM 149 124 14 13
WARFARIN SODIUM 143 140 15 7
DOXAZOSIN MESYLATE 139 115 16 60
TAMSULOSIN HCL 134 105 17 27
PRAVASTATIN SODIUM 128 115 18 17
METOPROLOL SUCCINATE 126 114 19 14
PREDNISONE 125 121 20 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 116 21 29
POTASSIUM CHLORIDE 119 116 22 15
TRAMADOL HCL 114 86 23 21
METFORMIN HCL 111 84 24 12
TRAZODONE HCL 109 78 25 45
ALLOPURINOL 107 106 26 22
ADVAIR DISKUS 104 95 27 31
DONEPEZIL HCL 101 101 28 24
LOSARTAN POTASSIUM 101 85 28 16
LOVASTATIN 96 85 30 26
GLYBURIDE 87 84 R 31 63
PAROXETINE HCL 87 86 31 64
ALENDRONATE SODIUM 84 84 33 20
CELEBREX 83 79 34 110
OXYCODONE-ACETAMINOPHEN 82 70 S2 35 62
SERTRALINE HCL 81 80 36 23
RANITIDINE HCL 81 77 36 42
NAMENDA 81 81 36 37
CLOPIDOGREL 78 78 39 36
TRIAMTERENE-HCTZ 78 55 39 33
DIOVAN 70 67 41 38
PANTOPRAZOLE SODIUM 68 65 42 34
ATENOLOL-CHLORTHALIDONE 66 66 43 177
RISPERIDONE 64 61 44 78
PROPRANOLOL HCL 63 61 45 103
CITALOPRAM HBR 61 59 46 19
ACETAMINOPHEN-CODEINE 60 50 S3 47 95
MIRTAZAPINE 59 53 48 35
CLONIDINE HCL 58 58 49 67
GLYBURIDE-METFORMIN HCL 56 52 R 50 132
FLUTICASONE PROPIONATE 56 51 50 40
SINGULAIR 52 35 52 151
METFORMIN HCL ER 52 49 52 49
TERAZOSIN HCL 52 52 52 99
VESICARE 51 49 55 138
FENOFIBRATE 51 47 55 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.